GASTRIC HYPOMOTILITY

This adverse event was reported 307 times

These drugs are most commonly taken by patients reporting GASTRIC HYPOMOTILITY:

# Drug Count
0 ORAL SEMAGLUTIDE 88
1 DULAGLUTIDE 87
2 METFORMIN 63
3 METFORMIN ER 500 MG 62
4 METFORMIN ER 750 MG 62
5 TIRZEPATIDE 62
6 INSULIN GLARGINE 39
7 GABAPENTIN 29
8 LISINOPRIL 24
9 PANTOPRAZOLE 24
See all common drugs associated with GASTRIC HYPOMOTILITY

GASTRIC HYPOMOTILITY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ERTUGLIFLOZIN AND METFORMIN HYDROCHLORIDE 1 0.0122
1 PEGVISOMANT 15 0.0037
2 THROMBIN HUMAN AND FIBRINOGEN 1 0.0030
3 ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE 1 0.0027
4 ESTERIFIED ESTROGENS, METHYLTESTOSTERONE 1 0.0027
5 PHENOBARBITAL SODIUM 1 0.0024
6 CYPROHEPTADINE HYDROCHLORIDE 7 0.0016
7 PRIMIDONE 15 0.0015
8 ORAL SEMAGLUTIDE 88 0.0011
9 PHENTERMINE HYDROCHLORIDE 7 0.0011
See all drugs enriched for association with GASTRIC HYPOMOTILITY

GASTRIC HYPOMOTILITY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Guanylate Cyclase-C Agonist [EPC] 7 0.0034
1 Human Blood Coagulation Factor [EPC] 1 0.0012
2 Androgen [EPC] 13 0.0005
3 Provitamin D2 Compound [EPC] 12 0.0004
4 mu-Opioid Receptor Agonist [EPC] 1 0.0003
5 GLP-1 Receptor Agonist [EPC] 144 0.0003
6 Calcitonin [EPC] 1 0.0003
7 Anticholinergic [EPC] 5 0.0003
8 Aluminum Complex [EPC] 7 0.0003
9 Dopamine and Norepinephrine Reuptake Inhibitor [EPC] 1 0.0003
See all drug classes enriched for association with GASTRIC HYPOMOTILITY